Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-07

Clinical Trial Update: RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor [NA]

View source ↗

Summary

A real-world evidence study evaluating the Cala Trio neuromodulation device for essential tremor has completed, with results to be reported separately.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cala Trio

Snippet

Sponsor: Cala Health, Inc. | Conditions: Essential Tremor | NA | Status: COMPLETED